Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
          
          https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
        Synthesis  2004(16): 2625-2628  
DOI: 10.1055/s-2004-831227
   DOI: 10.1055/s-2004-831227
PAPER
© Georg Thieme Verlag Stuttgart · New YorkEfficient Synthesis of 4-(3-Fluoro-5-{[4-(2-methyl-1H-imidazol-1-yl)benzyl]oxy}phenyl)tetrahydro-2H-pyran-4-carboxamide, a Novel 5-Lipoxygenase Inhibitor
Further Information
            
               
                  
                        
                              Received
                              19 April 2004 
                      
Publication Date:
22 September 2004 (online)
            
         
      
   Publication History
Publication Date:
22 September 2004 (online)

Abstract
An efficient synthesis of 1, a novel orally active 5-lipoxygenase inhibitor, was developed. Key features of the modified synthetic route include facile construction of the benzyl phenyl ether moiety by nucleophilic aromatic substitution and THP ring by cyclization, and base-promoted hydrolysis of the nitrile group to carboxamide. The improved three-step synthesis provides 25 g of 1 for pre-clinical toxicology studies in a total yield of 59%.
Key words
amides - cyclizations - drugs - nitriles - nucleophilic aromatic substitutions
- 1a 
             
            Samuelsson B. Science (Washington, D. C.) 1983, 220: 568
- 1b 
             
            Lewis RA.Austen KF.Soberman RJ. New Engl. J. Med. 1990, 323: 645
- 2 
             
            Henderson WR. J. Allergy Clin. Immunol. 1987, 79: 543
- 3a 
             
            Masamune H.Melvin LS. In Annual Reports in Medicinal Chemistry Vol. 24:Allen RC. Academic Press; San Diego: 1989. p.71-80Reference Ris Wihthout Link
- 3b 
             
            Jackson WT.Fleisch JH. In Progress in Drug Research Vol. 46:Jucker E. Birkhauser Verlag; Basel: 1996. p.115-168Reference Ris Wihthout Link
- 4 
             
            Mano T.Stevens RW.Ando K.Nakao K.Okumura Y.Sakakibara M.Okumura T.Tamura T.Miyamoto K. Bioorg. Med. Chem. 2003, 13: 3879
- 5 
             
            Mano T.Miyamoto K.Okumura T.Okumura Y.Sakakibara M.Tamura T.Stevens RW. J. Med. Chem. 2004, 47: 720
- 6 
             
            Stevens RV.Lai JT. J. Org. Chem. 1972, 37: 2138
- 7 
             
            Fleming I.Loreto MA.Wallace IHM.Michael JP. J. Chem. Soc., Perkin Trans. 1 1986, 349
- 8 
             
            Eisleb O. Chem. Ber. 1941, 74B: 1433
- 9 
             
            Lambert-van der Brempt C.Bruneau P.Lamorlette M.Foster S. J. Med. Chem. 1994, 37: 113
- 10 
             
            Thompson D.Reeves P. J. Heterocycl. Chem. 1983, 20: 771
- 11 
             
            Kisel’ VM.Platonov MO.Kostyrko EO.Kovtunenko VR. Chem. Heterocycl. Compd. 2000, 36: 905
- 12a 
             
            Robertson DW.Krushinski JH.Fuller RW.Leander JD. J. Med. Chem. 1988, 31: 1412
- 12b 
             
            Martínez-Esparza J.Oficialdegui A.-M.Pérez-Silanes S.Heras B.Orús L.Palop J.-A.Lasheras B.Roca J.Mourelle M.Bosch A.Del Castillo J.-C.Tordera R.Del RoJ.Monge A. J. Med. Chem. 2001, 44: 418
- 13 
             
            Katritzky AR.Pilarski B.Urogdi L. Synthesis 1989, 949
- 14a 
             
            Hall JH.Gisler M. J. Org. Chem. 1976, 41: 3769
- 14b 
             
            Popov SA.Rukavishnikov AV.Tkachev AV. Synthesis 1992, 783
- 14c 
             
            Felpin F.-X.Doris E.Wagner A.Valleix A.Rousseau B.Mioskowski C. J. Org. Chem. 2001, 66: 305
- 14d 
             
            Engler TA.Furness K.Malhotra S.Sanchez-Martinez C.Shih C.Xie W.Zhu G.Zhou X.Conner S.Faul MM.Sullivan KA.Kolis SP.Brooks HB.Patel B.Schultz RM.DeHahn TB.Kirmani K.Spencer CD.Watkins SA.Considine EL.Dempsey JA.Ogg CA.Stamm NB.Anderson BD.Campbell RM.Vasudevan V.Lytle ML. Bioorg. Med. Chem. 2003, 13: 2261
 
    